But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers to ...

The non-profit watchdog organization American Oversight sued the Trump administration on Monday for “unlawfully withholding ...